GlassScriptPhysician profile
Malorie S Howe
NPI 1518340926
$3,791.09
in general payments reported to CMS, 2019-2025
25 companies · $595 in 2025
The $595 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $72.19 · 2021: $594 · 2022: $999 · 2023: $658 · 2024: $752 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,004.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $743.13 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $488.08 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $409.17 | 2023-2025 | Myfembree |
| Pfizer INC. | $322.49 | 2021-2024 | |
| Biogen, INC. | $311.46 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $196.16 | 2021-2022 | |
| Daiichi Sankyo INC. | $144.62 | 2019-2023 | Injectafer |
| Exeltis, USA INC. | $125.50 | 2019-2025 | Slynd |
| Lilly USA, LLC | $119.82 | 2024 | Zepbound |
| Organon LLC | $116.66 | 2021-2025 | Nexplanon, Jada System |
| Intuitive Surgical, INC. | $107.14 | 2022 | |
| Astellas Pharma US INC | $100.08 | 2023-2025 | Veozah |
| Millicent US INC | $99.08 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Shield Therapeutics INC | $87.59 | 2024 | |
| Coopersurgical, INC. | $86.67 | 2021-2025 | Paragard T 380a |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $75.82 | 2019-2022 | |
| Conmed Corporation | $71.43 | 2022 | |
| Agile Therapeutics, INC. | $44.64 | 2021-2022 | |
| Hologic Sales and Service, LLC | $30.27 | 2022 | |
| Avion Pharmaceuticals | $27.33 | 2021-2022 | |
| Gynesonics, INC. | $22.48 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Aspira Women'S Health INC | $20.56 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.47 | 2019 | |
| Evofem Biosciences, INC. | $13.41 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malorie Howe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.